GANIRELIX EG 0.25 mg/0.5 ml, solution for injection in a pre-filled syringe syringe, 0.5 ml
Active ingredients: Ganirelix acetate, Ganirelix
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 0.5 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GANIRELIX EG 0,25 mg/0,5 mL, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 seringue préremplie en verre avec aiguille de 0,5 mL
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 May 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61125958CIP73026898CIP133400930268988Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GANIRÉLIXsolution | 0,25 mg · une seringue préremplie de 0,5 mL | FT |
| ACÉTATE DE GANIRÉLIXsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.